PPAR-related mechanisms have been used in experimental models to inhibit key genes involved in tumorigenesis, such as matrix metalloproteinase 2 (MMP-2) in the lung adenocarcinoma cell line A549 [124]. This evidence concerns the gene MMP2 and lung adenocarcinoma.